Skip to content
Dose Brief
Menu

Maves review

By Updated

Maves lists a first-month discount for both medications. Compare the price you would pay after it ends.

Brief Score75/100Grade CNo. 95 in our directory
Visit Maves View the provider’s current plans and terms.
Semaglutide

$189 first month, then $249/mo for compounded semaglutide.

Tirzepatide

$249 first month, then $349/mo for compounded tirzepatide.

Coverage
Maves says prescription availability varies by state.
Brand-name
Not confirmed

Prices checked against Maves's published terms in . Providers change pricing without notice — check the current figure before you buy.

On the trackerNewnew to the tracker, no prior reading— Both medications cost more after the first month.

Maves in depth

What you pay after the first month

The GLP-1 treatment page (opens in a new tab) lists semaglutide at $189 initially and $249 afterward, and tirzepatide at $249 initially and $349 afterward. Use the billing guide once you have the quote for your plan. Compare the recurring price across providers, since the first-month rate applies only once.

The treatment page describes compounded medication after a clinician’s review. Use the pharmacy checklist to ask which pharmacy and preparation would apply. Compounded medications are not FDA-approved.

Check the terms for your plan

Maves’ telehealth consent (opens in a new tab) points to the enrollment offer and terms for billing. The general terms (opens in a new tab) describe a Homera Health membership for testosterone treatment. Confirm the cadence and refund conditions for the GLP-1 offer itself.

The treatment page says you can cancel anytime. Use the refund checklist to check when you need to cancel to avoid the next charge and whether you can get a refund for an order the pharmacy is already preparing. The current treatment page does not specify those terms.

Sources we checked

Public program pages and terms, checked November 2026. We have not enrolled in treatment or independently tested the medication.

This source update covers the review text and stated program terms. The existing numerical score has not been recalculated from this check; it should not be read as a new validation of every score factor.

The scorecard

Maves scored on our six Brief Score factors. See the methodology.

Price Stability48/100
Supply Reliability79/100
Transparency88/100
Access Breadth86/100
Clinical Oversight75/100
Track Record87/100

What we like

  • Lists the first-month and recurring prices separately
  • Describes clinical review before prescribing
  • Advertises cancellation at any time

The caveats

  • Both prices rise after the first month
  • The general membership terms describe a different treatment program
  • The treatment page does not give a cancellation cutoff

The brief

Best for: Readers who can verify their exact first charge, refill price and dispensing pharmacy. Maves lists a first-month discount for both medications. Compare the price you would pay after it ends.

Ranked #95 of 546 providers we reviewed — compare with CoreAge Rx, for comparison.

Before you decide

The questions readers ask next after reading about Maves.

Closest here

The providers scoring nearest Maves — read each current assessment before choosing care.

Weighing Maves against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs Maves, and every provider that outranks it is listed on the Maves alternatives ranking.

More providers we track (24)

514 more are filed too — see every provider we track, ranked.

Pricing, states and verification reflect Maves's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on Maves's site. Not medical advice; see our disclosure.

← Back to all rankings